Paleo is a Brussels, Belgium–based precision fermentation company that focuses on producing myoglobin to recreate the color, smell, taste, and aromatic experience of meat and fish. Led by CEO Hermes Sanctorum and COO Andy de Jong, Paleo offers a protein portfolio spanning six species: beef, chicken, pork, lamb, tuna, and mammoth. Its myoglobin ingredient is intended to give food manufacturers a “real taste” experience while adding nutritional value to environmentally friendly and cruelty-free alternatives. The company raised €12M in a Series A round to support its plans. Paleo intends to use the funds to scale its technology, move toward commercial production, and file for regulatory approval in key markets. Paleo develops proteins through precision fermentation to be used in meat and fish alternative products, aiming to improve taste, texture and nutritional value. The company says it is working on production processes for six key meat and fish proteins and is expanding its portfolio. Paleo positions itself as a European pioneer in precision fermentation for meat and fish proteins. The seed capital will fund continued R&D and the design of an R&D centre, a pilot plant and an experience centre. Management says a planned €40 million Series A will finance construction of those facilities. Leadership includes CEO Hermes Sanctorum and co-founder/COO Andy de Jong, who note growing interest from European and US investors.

Total raised

$15M

Funding rounds

2

Latest round

Series A

Latest activity

Feb 2023